Thromboembolic events in people with cancer during the COVID-19 pandemic: case-control study.
Vivian Cristina Gama Souza LimaPaulo Jorge Pereira AlvesPatrícia Claro Dos Santos FulyPublished in: Revista latino-americana de enfermagem (2024)
(1) Deep vein thrombosis was what prevailed in the studied population. (2) Chemotherapy increased the chance of thromboembolic events by 65%. (3) Thromboembolic events showed a significant association with a higher death rate as the outcome. (4) COVID-19 did not increase the risk of thromboembolic events in people with cancer.